SANOFI
Updates & Highlights
Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay
Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay
BioSpace · about 7 hours ago
Bicara Therapeutics hires Replimune, Sanofi alum as chief commercial officer
Bicara Therapeutics hires Replimune, Sanofi alum as chief commercial officer
Fierce Pharma · 1 day ago
Sanofi: Great Yield And Plenty Of Upside Potential (NASDAQ:SNY)
Sanofi: Great Yield And Plenty Of Upside Potential (NASDAQ:SNY)
Seeking Alpha · 2 days ago
Recent Openings
View all 3 jobsAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Parental Leave
Family-friendly policies
Competitive Salary
Market-rate compensation
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Sanofi?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
20 recentSanofi S.A. stock (FR0000120578): Q1 2026 results reviewed on April 23
Sanofi S.A. stock (FR0000120578): Q1 2026 results reviewed on April 23
AD HOC NEWS · 41 minutes ago
Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay
Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay
BioSpace · about 7 hours ago
Sanofi SA Stock 12‑Month Price Target Raised to €97.2, Implies 32% Upside
Sanofi SA Stock 12‑Month Price Target Raised to €97.2, Implies 32% Upside
TradingView · about 15 hours ago
USPTO Must Address The Right Question In Sanofi Case
USPTO Must Address The Right Question In Sanofi Case
Law360 · about 23 hours ago
Bicara Therapeutics hires Replimune, Sanofi alum as chief commercial officer
Bicara Therapeutics hires Replimune, Sanofi alum as chief commercial officer
Fierce Pharma · 1 day ago
Sanofi: Great Yield And Plenty Of Upside Potential (NASDAQ:SNY)
Sanofi: Great Yield And Plenty Of Upside Potential (NASDAQ:SNY)
Seeking Alpha · 2 days ago
Eduardo Dominguez of VML Health on ‘Chasing the Miracles of Science’ for Sanofi
Eduardo Dominguez of VML Health on ‘Chasing the Miracles of Science’ for Sanofi
Muse by Clio · 4 days ago
Sanofi Leans On AI And Rare Disease Detection To Shape Future Returns
Sanofi Leans On AI And Rare Disease Detection To Shape Future Returns
Yahoo Finance · 5 days ago
Novo Nordisk Beats Sanofi To Keep Injection Pen Patent
Novo Nordisk Beats Sanofi To Keep Injection Pen Patent
Law360 · 6 days ago
Sanofi Withdraws Teplizumab from FDA Fast-Track Review After May 7, 2026 Disagreement
Sanofi Withdraws Teplizumab from FDA Fast-Track Review After May 7, 2026 Disagreement
geneonline.com · 6 days ago
Pharmalittle: We're reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more
Pharmalittle: We're reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more
statnews.com · 6 days ago
Sanofi requests removal of Tzield from CNPV program after Høeg gets involved
Sanofi requests removal of Tzield from CNPV program after Høeg gets involved
BioSpace · 6 days ago
Pentoxifylline Drug Market Is Going to Boom Rapidly | Sanofi India Ltd, ANI Pharmaceuticals Inc, Cipla Ltd
Pentoxifylline Drug Market Is Going to Boom Rapidly | Sanofi India Ltd, ANI Pharmaceuticals Inc, Cipla Ltd
The National Law Review · 6 days ago
Sanofi (NYSE: SNY) reports 9 holdings totaling $335.96M in Form 13F
Sanofi (NYSE: SNY) reports 9 holdings totaling $335.96M in Form 13F
Stock Titan · 6 days ago
Sanofi expanding AI Centre of Excellence in Toronto
Sanofi expanding AI Centre of Excellence in Toronto
Ontario Construction News · 6 days ago
Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
Fierce Pharma · 7 days ago
Sanofi asks to pull diabetes drug out of FDA voucher program, STAT News reports
Sanofi asks to pull diabetes drug out of FDA voucher program, STAT News reports
Reuters · 7 days ago
Sanofi’s Dynavax Deal Reshapes Vaccine Portfolio And Valuation Narrative
Sanofi’s Dynavax Deal Reshapes Vaccine Portfolio And Valuation Narrative
Yahoo Finance · 7 days ago
Sanofi supports AlphaDetect to accelerate detection of Alpha-1
Sanofi supports AlphaDetect to accelerate detection of Alpha-1
marketscreener.com · 7 days ago
More than 90% of Alpha-1 cases go unidentified; Sanofi backs testing
More than 90% of Alpha-1 cases go unidentified; Sanofi backs testing
Stock Titan · 7 days ago